Clinical Trials Logo

Clinical Trial Summary

This study will conducted to evaluate and comparison between the effectiveness, safety and acceptability of lactoferrin alone, ferrous fumarate alone and combination of both for the treatment of mild to moderate IDA during pregnancy.


Clinical Trial Description

Anemia in pregnancy is a major public health problem, where it has been estimated that 41.8% of pregnant women worldwide are anemic .

Iron deficiency anemia (IDA) is the condition in which there is anemia due to a lack of iron. IDA develops when available iron is insufficient to support normal red cell production and is the most common type of anemia Anemia has a significant impact on the health of the fetus as well as that of the mother. It impairs the oxygen delivery through the placenta to the fetus and interferes with the normal intrauterine growth, leading to fetal loss and perinatal deaths. Anemia is associated with increased preterm labor (28.2%), preeclampsia (31.2%), and maternal sepsis.

The daily requirement of iron is around 1.5 mg in nonpregnant women. This requirement increases dramatically during pregnancy to reach 6-7 mg/day (total 1000 mg) with advanced gestational age. Pregnancy causes a twofold to threefold increase in the requirement for iron and a 10- to 20-fold increase in folate requirement. The increase in demand for iron is mainly due to fetal requirement, placenta, blood volume, tissue accretion, and the intra-partum potential for blood loss ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03484845
Study type Interventional
Source Assiut University
Contact amaal khalil, master
Phone 02201154883113
Email amaal.moussa@gmail.com
Status Not yet recruiting
Phase Phase 1/Phase 2
Start date November 1, 2018
Completion date December 1, 2019

See also
  Status Clinical Trial Phase
Completed NCT03456258 - Lactoferrin Versus Ferrous Sulphate for the Treatment of Iron Deficiency Anemia During Pregnancy N/A
Not yet recruiting NCT04074707 - Defining a Dosing Regimen With Maximal Absorption for Oral Iron Supplementation During Pregnancy N/A
Completed NCT03481790 - Lactoferrin Versus Ferrous Sulphate for Treatment of Iron Deficiency Anaemia During Pregnancy Phase 2
Terminated NCT04594070 - Daily Versus Alternate Day Iron Supplementation for the Treatment of Iron Deficiency Anemia in Pregnancy Phase 4
Completed NCT03706638 - Daily vs Intermittent Iron Therapy in Pregnancy N/A
Recruiting NCT06366698 - Intravenous Iron Versus Oral Iron for the Treatment of Iron Deficiency Anemia Phase 3
Not yet recruiting NCT06425796 - Adiposity and Iron Requirements in Pregnancy N/A
Completed NCT03961074 - Iron Deficiency Anemia Among Chinese Pregnant Women: a Multi-center Prospective Cohort Study
Recruiting NCT05804071 - Analysis of the Effect of Iron Supplements on Iron Deficiency Anemia in Pregnancy Phase 4
Recruiting NCT04008147 - Hepcidin and Glucose Metabolism N/A
Completed NCT03188445 - Intravenous Iron Isomaltoside Versus Oral Iron Supplementation for Treatment of Iron Deficiency in Pregnancy. Phase 4
Completed NCT05157828 - Iron Deficiency Anaemia in Pregnant Patients Presenting for Antenatal Care
Active, not recruiting NCT05545527 - Neuroimaging Ancillary Study
Completed NCT05725278 - Impact Evaluation of Triggerise's Tiko Platform N/A
Completed NCT03378791 - Efficacy of Iron Bisglycinate in Treatment of Iron Deficiency Anemia in Pregnant Women Phase 3
Completed NCT02005588 - Treatment of Iron Deficiency Anemia With Pregnancy Phase 0
Completed NCT03657433 - Intravenous Infusions of Ferumoxytol Compared to Oral Ferrous Sulfate for the Treatment of Anemia in Pregnancy Phase 3
Completed NCT04976179 - Iron Infusion Into a Vein Compared to Iron Tablet Taken by Mouth for Treating Iron Deficiency Anemia in Pregnancy (IVON) Phase 3
Completed NCT03438227 - Intravenous Iron for Iron-deficiency Anemia in Pregnancy: a Randomized Controlled Trial Phase 4
Available NCT05151679 - Chelated Oral Iron Versus Intravenous Iron Sucrose for Treatment of Iron Deficiency Anemia Late in Pregnancy